Hemafer (Iron)

Hemafer is commonly used to address conditions related to insufficient iron levels.

• Treatment of iron deficiency anemia in adults.
• Prevention of iron deficiency in individuals with increased physiological demand, such as menstruating women.
• Support for patients recovering from blood loss due to surgery or trauma.
• Adjunct therapy for chronic diseases associated with anemia, like chronic kidney disease.
• Nutritional supplementation for vegetarians or vegans with low dietary iron intake.
• Management of iron deficiency in pregnancy under medical supervision.
• Correction of iron deficiency in children with growth monitoring.

Possible side effects of oral iron supplementation such as Hemafer vary in frequency and severity.

Common

• Gastrointestinal discomfort, including nausea or abdominal cramping.
• Constipation or loose stools.
• Darkening of the stool color.
• Metallic taste in the mouth.
• Mild heartburn.
• Transient loss of appetite.
• Mild dizziness.
• Temporary increase in bowel sounds.
• Mild headache.

Serious

• Severe allergic reaction with rash, itching, swelling, or difficulty breathing.
• Significant gastrointestinal bleeding.
• Iron overload leading to organ damage (rare with recommended dosing).
• Anaphylaxis (extremely rare).
• Severe abdominal pain with vomiting.
• Persistent vomiting leading to dehydration.
• Seizures associated with severe iron toxicity.
• Kidney dysfunction in patients with pre-existing renal disease.

When using Hemafer, certain precautions should be observed to minimize risks and ensure safe administration.

• Do not exceed the recommended daily amount without medical advice.
• Store the product away from moisture and out of reach of children.
• Use caution in individuals with a history of gastrointestinal disorders.
• Monitor for signs of iron overload during long‑term use.
• Avoid taking Hemafer simultaneously with antacids or calcium supplements that may reduce absorption.
• Pregnant or breastfeeding women should consult a healthcare professional before use.
• Patients with chronic kidney disease should have iron status evaluated regularly.

Hemafer may interact with certain medications or nutrients, affecting iron absorption or increasing the risk of adverse effects.

Avoid

• Concurrent use of tetracycline antibiotics.
• Simultaneous intake of levothyroxine.
• Co‑administration with proton pump inhibitors (may reduce absorption).
• Iron chelating agents such as deferoxamine.
• Methyldopa therapy.

Use with caution

• Antacids containing aluminum, magnesium, or calcium.
• Calcium‑rich foods or supplements taken close to dosing.
• Certain food dyes or phytates that can bind iron.
• High‑dose vitamin C may increase iron absorption, requiring monitoring.
• Oral bisphosphonates taken within 2 hours of iron may have reduced efficacy.
• Concurrent use of certain diuretics may affect electrolyte balance when combined with iron supplements.